Bodycote plc

As of December 31, 2025, Bodycote plc carries a market capitalization of 120.44B, placing it among publicly traded companies globally. Its enterprise value stands at 137.17B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bodycote plc's next confirmed earnings release is scheduled for March 12, 2027.

As of December 31, 2025, Bodycote plc has 172.55M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Bodycote plc maintains a current ratio of 1.17, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Bodycote plc's stock has gained approximately 37.57% over the past 52 weeks. The 50-day moving average sits at 925.25, while the 200-day moving average is 772.83.

As of December 31, 2025, Bodycote plc holds 2.52B in cash and equivalents against 19.08B in total debt, resulting in a net debt position of 10.48B. Total book value stands at 64.02B, with working capital of 3.19B providing operational flexibility.

Bodycote plc's most recent stock split took place on December 9, 2008 with a 19:11 split ratio.